O	O	O	0	7	Genomic	Genomic	B-NP	JJ	O	8	NMOD	O
O	O	O	8	20	organization	organization	I-NP	NN	O	1	NMOD	O
O	O	O	20	21	,	,	O	,	O	1	P	O
O	O	O	22	30	sequence	sequence	B-NP	NN	O	1	NMOD	O
O	O	O	30	31	,	,	O	,	O	8	P	O
O	O	O	32	35	and	and	O	CC	O	8	NMOD	O
O	O	O	36	51	transcriptional	transcriptional	B-NP	JJ	O	8	NMOD	O
O	O	O	52	62	regulation	regulation	I-NP	NN	O	0	ROOT	O
O	O	O	63	65	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	66	69	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	70	75	human	human	I-NP	JJ	B-DNA	13	NMOD	B-DNA
T1	B-Protein	B-Protein	76	83	eotaxin	eotaxin	I-NP	NN	I-DNA	13	NMOD	I-DNA
O	O	O	84	88	gene	gene	I-NP	NN	I-DNA	9	PMOD	I-DNA
O	O	O	88	89	.	.	O	.	O	8	P	O

T2	B-Protein	B-Protein	91	98	Eotaxin	Eotaxin	B-NP	NN	B-protein	2	SUB	B-protein
O	O	O	99	101	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	102	104	an	an	B-NP	DT	O	8	NMOD	O
O	O	O	105	115	eosinophil	eosinophil	I-NP	NN	B-protein	6	NMOD	B-protein
O	O	O	116	124	specific	specific	B-NP	JJ	I-protein	6	NMOD	I-protein
O	O	O	125	129	beta	beta	I-NP	SYM	I-protein	7	AMOD	I-protein
O	O	O	129	130	-	-	I-NP	HYPH	O	8	NMOD	O
O	O	O	130	139	chemokine	chemokine	I-NP	NN	B-protein	2	PRD	B-protein
O	O	O	140	147	assumed	assume	B-VP	VBN	O	8	NMOD	O
O	O	O	148	150	to	to	I-VP	TO	O	11	VMOD	O
O	O	O	151	153	be	be	I-VP	VB	O	9	VMOD	O
O	O	O	154	162	involved	involve	I-VP	VBN	O	11	VC	O
O	O	O	163	165	in	in	B-PP	IN	O	12	VMOD	O
O	O	O	166	178	eosinophilic	eosinophilic	B-NP	JJ	O	15	AMOD	O
O	O	O	179	191	inflammatory	inflammatory	I-NP	JJ	O	16	NMOD	O
O	O	O	192	200	diseases	disease	I-NP	NNS	O	13	PMOD	O
O	O	O	201	205	such	such	B-PP	JJ	O	18	PMOD	O
O	O	O	206	208	as	as	I-PP	IN	O	16	NMOD	O
O	O	O	209	215	atopic	atopic	B-NP	JJ	O	20	NMOD	O
O	O	O	216	226	dermatitis	dermatitis	I-NP	NN	O	28	NMOD	O
O	O	O	226	227	,	,	O	,	O	28	P	O
O	O	O	228	236	allergic	allergic	B-NP	JJ	O	23	NMOD	O
O	O	O	237	245	rhinitis	rhinitis	I-NP	NN	O	28	NMOD	O
O	O	O	245	246	,	,	O	,	O	28	P	O
O	O	O	247	253	asthma	asthma	B-NP	NN	O	28	NMOD	O
O	O	O	254	257	and	and	O	CC	O	28	NMOD	O
O	O	O	258	267	parasitic	parasitic	B-NP	JJ	O	28	NMOD	O
O	O	O	268	278	infections	infection	I-NP	NNS	O	18	PMOD	O
O	O	O	278	279	.	.	O	.	O	2	P	O

O	O	O	280	283	Its	Its	B-NP	PRP$	O	2	NMOD	O
O	O	O	284	294	expression	expression	I-NP	NN	O	3	SUB	O
O	O	O	295	297	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	298	306	stimulus	stimulus	B-NP	NN	O	9	AMOD	O
O	O	O	306	307	-	-	B-ADJP	HYPH	O	4	P	O
O	O	O	308	311	and	and	O	CC	O	4	NMOD	O
O	O	O	312	316	cell	cell	B-NP	NN	O	4	NMOD	O
O	O	O	316	317	-	-	B-ADJP	HYPH	O	9	AMOD	O
O	O	O	317	325	specific	specific	I-ADJP	JJ	O	3	PRD	O
O	O	O	325	326	.	.	O	.	O	3	P	O

O	O	O	327	329	We	We	B-NP	PRP	O	3	SUB	O
O	O	O	330	334	here	here	B-ADVP	RB	O	3	VMOD	O
O	O	O	335	343	describe	describe	B-VP	VBP	O	0	ROOT	O
O	O	O	344	347	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	348	355	genomic	genomic	I-NP	JJ	O	6	NMOD	O
O	O	O	356	368	organisation	organisation	I-NP	NN	O	27	NMOD	O
O	O	O	369	370	(	(	O	(	O	25	DEP	O
O	O	O	370	371	3	3	B-NP	CD	O	18	NMOD	O
T7	B-Entity	B-Entity	372	377	exons	exon	I-NP	NNS	B-DNA	8	NMOD	B-DNA
O	O	O	378	380	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	381	384	132	132	B-NP	CD	O	16	NMOD	O
O	O	O	384	385	,	,	I-NP	,	O	16	P	O
O	O	O	386	389	112	112	I-NP	CD	O	16	NMOD	O
O	O	O	390	393	and	and	I-NP	CC	O	16	NMOD	O
O	O	O	394	397	542	542	I-NP	CD	O	16	NMOD	O
O	O	O	398	400	bp	bp	I-NP	NN	O	10	PMOD	O
O	O	O	401	404	and	and	O	CC	O	18	NMOD	O
O	O	O	405	406	2	2	B-NP	CD	O	25	DEP	O
T8	B-Entity	B-Entity	407	414	introns	intron	I-NP	NNS	B-DNA	18	NMOD	B-DNA
O	O	O	415	417	of	of	B-PP	IN	O	18	NMOD	O
O	O	O	418	422	1211	1211	B-NP	CD	O	24	NMOD	O
O	O	O	423	426	and	and	I-NP	CC	O	24	NMOD	O
O	O	O	427	430	378	378	I-NP	CD	O	24	NMOD	O
O	O	O	431	433	bp	bp	I-NP	NN	O	20	PMOD	O
O	O	O	433	434	)	)	O	)	O	6	NMOD	O
O	O	O	435	438	and	and	O	CC	O	27	NMOD	O
O	O	O	439	447	sequence	sequence	B-NP	NN	O	3	OBJ	O
O	O	O	448	457	including	include	B-PP	VBG	O	27	NMOD	O
O	O	O	458	459	3	3	B-NP	CD	O	30	NMOD	O
O	O	O	460	462	kb	kb	I-NP	NN	O	28	PMOD	O
O	O	O	463	465	of	of	B-PP	IN	O	30	NMOD	O
O	O	O	466	469	DNA	DNA	B-NP	NN	O	31	PMOD	O
O	O	O	470	474	from	from	B-PP	IN	O	30	NMOD	O
O	O	O	475	478	the	the	B-NP	DT	O	39	NMOD	O
O	O	O	479	488	immediate	immediate	I-NP	JJ	B-DNA	38	AMOD	B-DNA
T9	B-Entity	B-Entity	489	490	5	5	I-NP	CD	I-DNA	38	AMOD	I-DNA
T9	I-Entity	I-Entity	490	491	'	'	I-NP	SYM	I-DNA	38	AMOD	I-DNA
T9	I-Entity	I-Entity	492	500	upstream	upstream	I-NP	JJ	I-DNA	39	NMOD	I-DNA
T9	I-Entity	I-Entity	501	507	region	region	I-NP	NN	I-DNA	33	PMOD	I-DNA
O	O	O	508	510	of	of	B-PP	IN	O	39	NMOD	O
O	O	O	511	514	the	the	B-NP	DT	O	44	NMOD	O
O	O	O	515	520	human	human	I-NP	JJ	B-DNA	44	NMOD	B-DNA
T3	B-Protein	B-Protein	521	528	eotaxin	eotaxin	I-NP	NN	I-DNA	44	NMOD	I-DNA
O	O	O	529	533	gene	gene	I-NP	NN	I-DNA	40	PMOD	I-DNA
O	O	O	533	534	.	.	O	.	O	3	P	O

O	O	O	535	540	Among	Among	B-PP	IN	O	23	VMOD	O
O	O	O	541	544	the	the	B-NP	DT	O	5	NMOD	O
T10	B-Entity	B-Entity	545	555	regulatory	regulatory	I-NP	JJ	B-DNA	5	NMOD	B-DNA
T10	I-Entity	I-Entity	556	564	promoter	promoter	I-NP	NN	I-DNA	5	NMOD	I-DNA
T10	I-Entity	I-Entity	565	573	elements	element	I-NP	NNS	I-DNA	1	PMOD	I-DNA
O	O	O	574	585	potentially	potentially	B-VP	RB	O	7	VMOD	O
O	O	O	586	596	regulating	regulate	I-VP	VBG	O	5	NMOD	O
T4	B-Protein	B-Protein	597	604	eotaxin	eotaxin	B-NP	NN	B-DNA	9	NMOD	B-DNA
O	O	O	605	609	gene	gene	I-NP	NN	I-DNA	10	NMOD	I-DNA
O	O	O	610	620	expression	expression	I-NP	NN	O	7	OBJ	O
O	O	O	621	624	and	and	O	CC	O	12	NMOD	O
O	O	O	624	625	/	/	B-NP	SYM	O	5	NMOD	O
O	O	O	625	627	or	or	O	CC	O	12	DEP	O
O	O	O	628	637	mediating	mediate	B-VP	VBG	O	5	NMOD	O
O	O	O	638	641	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	642	649	effects	effect	I-NP	NNS	O	14	OBJ	O
O	O	O	650	652	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	653	657	anti	anti	B-NP	AFX	O	21	NMOD	O
O	O	O	657	658	-	-	I-NP	HYPH	O	21	NMOD	O
O	O	O	658	670	inflammatory	inflammatory	I-NP	JJ	O	21	NMOD	O
O	O	O	671	676	drugs	drug	I-NP	NNS	O	17	PMOD	O
O	O	O	677	679	we	we	B-NP	PRP	O	23	SUB	O
O	O	O	680	690	identified	identify	B-VP	VBD	O	0	ROOT	O
T11	B-Entity	B-Entity	691	700	consensus	consensus	B-NP	NN	B-DNA	25	NMOD	B-DNA
T11	I-Entity	I-Entity	701	710	sequences	sequence	I-NP	NNS	I-DNA	23	OBJ	I-DNA
O	O	O	711	716	known	know	B-VP	VBN	O	25	NMOD	O
O	O	O	717	719	to	to	B-VP	TO	O	28	VMOD	O
O	O	O	720	728	interact	interact	I-VP	VB	O	26	VMOD	O
O	O	O	729	733	with	with	B-PP	IN	O	28	VMOD	O
O	O	O	734	741	nuclear	nuclear	B-NP	JJ	B-protein	31	NMOD	B-protein
O	O	O	742	749	factors	factor	I-NP	NNS	I-protein	29	PMOD	I-protein
O	O	O	750	754	like	like	B-PP	IN	O	28	VMOD	O
T5	B-Protein	B-Protein	755	757	NF	NF	B-NP	NN	B-protein	38	NMOD	B-protein
T5	I-Protein	I-Protein	757	758	-	-	O	HYPH	O	38	NMOD	O
T5	I-Protein	I-Protein	758	761	IL6	IL6	B-NP	NN	B-protein	38	NMOD	B-protein
O	O	O	761	762	,	,	O	,	O	38	P	O
T12	B-Entity	B-Entity	763	765	AP	AP	B-NP	NN	B-protein	38	NMOD	B-protein
T12	I-Entity	I-Entity	765	766	-	-	B-NP	HYPH	I-protein	53	NMOD	I-protein
T12	I-Entity	I-Entity	766	767	1	1	I-NP	CD	I-protein	38	NMOD	I-protein
O	O	O	767	768	,	,	O	,	O	38	P	O
O	O	O	769	770	a	a	B-NP	DT	O	49	NMOD	O
T13	B-Entity	B-Entity	771	773	NF	NF	I-NP	NN	B-DNA	49	NMOD	B-DNA
T13	I-Entity	I-Entity	773	774	-	-	B-NP	HYPH	I-DNA	49	NMOD	I-DNA
T13	I-Entity	I-Entity	774	779	kappa	kappa	I-NP	NN	I-DNA	49	NMOD	I-DNA
T13	I-Entity	I-Entity	779	780	-	-	B-NP	HYPH	I-DNA	49	NMOD	I-DNA
T13	I-Entity	I-Entity	780	781	B	B	I-NP	NN	I-DNA	49	NMOD	I-DNA
T13	I-Entity	I-Entity	782	786	like	like	I-NP	JJ	I-DNA	49	NMOD	I-DNA
T13	I-Entity	I-Entity	787	796	consensus	consensus	I-NP	NN	I-DNA	49	NMOD	I-DNA
T13	I-Entity	I-Entity	797	805	sequence	sequence	I-NP	NN	I-DNA	53	NMOD	I-DNA
O	O	O	806	809	and	and	O	CC	O	53	NMOD	O
T6	B-Protein	B-Protein	810	815	gamma	gamma	B-NP	SYM	B-protein	53	NMOD	B-protein
T6	I-Protein	I-Protein	815	816	-	-	B-NP	HYPH	I-protein	53	NMOD	I-protein
T6	I-Protein	I-Protein	816	826	interferon	interferon	I-NP	NN	I-protein	60	NMOD	I-protein
O	O	O	826	827	-	-	O	HYPH	O	60	P	O
O	O	O	828	830	as	as	B-CONJP	RB	O	60	NMOD	O
O	O	O	831	835	well	well	I-CONJP	RB	O	55	DEP	O
O	O	O	836	838	as	as	I-CONJP	IN	O	55	DEP	O
O	O	O	839	853	glucocorticoid	glucocorticoid	B-NP	NN	B-DNA	60	NMOD	B-DNA
T14	B-Entity	B-Entity	854	862	response	response	I-NP	NN	I-DNA	60	NMOD	I-DNA
T14	I-Entity	I-Entity	863	871	elements	element	I-NP	NNS	I-DNA	32	PMOD	I-DNA
O	O	O	871	872	.	.	O	.	O	23	P	O
